This was further realized in 2017 with the addition of a radiopharmacy network with global distribution capabilities. Our product lines include fdg, pylarify, neuraceq, and other clinical trial products. With its robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value theranostic intellectual property, sofie is poised to deliver on the promise of radiopharmaceuticals. Transparency in coverage (tic) regulations requires health insurers and group health plans to post their provider link on company websites View sofie’s link here view our privacy policy Contact us contact us for more information about our tracers or research
Sofie 21000 atlantic blvd., ste 730 dulles, va 20166 phone +1 703 787 7900 for general inquiries Sofie wishes to thank our esteemed speakers and panelists for their participation, and all who attended The video recording of the session is available to view here. We are currently performing data analysis and behind the scenes planning for phase 3 is well underway. Sofie’s network will help meet the expected commercial demand for pylarify by leveraging our expertise, experience, and distribution capabilities to successfully help serve the u.s
OPEN
